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Objective: Poor descriptions of standard care may compromise interpretation
of results in randomised controlled trials (RCTs) of health interventions. We
investigated quality of standard care in RCTs of behaviour change interven-
tions for young people with type 1 diabetes and consider implications for
evaluating trial outcomes.
Design: We conducted systematic searches for articles published between
1999 and 2012. We extracted standard care descriptions and contacted trial
authors to complete a checklist of standard care activities. The relationship
between standard care quality and outcomes was examined via subgroup
meta-analyses and meta-regression.
Main outcome measures: Standard care descriptions, standard care quality,
and relationships between standard care quality with medical and psychologi-
cal outcomes.
Results: We identiﬁed 20 RCTs described across 26 articles. Published
descriptions of standard care were limited to service-level features. Author
responses indicated standard care provision extended beyond published
accounts. Subgroup analyses suggested control groups receiving higher stan-
dard care quality showed larger improvements in both medical and psycholog-
ical outcomes, although standard care quality did not predict outcomes
signiﬁcantly.
Conclusion: The quality of care delivered to control group participants can
inﬂuence outcomes of RCTs. Inadequate reporting exacerbates this issue by
masking variations between trials. We argue for increased clarity in reporting
standard care in future trials.
Keywords: type 1 diabetes; control group; reporting; meta-analysis; standard
care quality
Introduction
Randomised controlled trials (RCTs) are generally considered to represent the gold
standard for evaluating health care interventions (Coates, 2010). By deﬁnition, such
trials involve the comparison of outcomes between two or more groups (usually an
intervention vs. a control), meaning the relative efﬁcacy of the control condition plays
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an integral part in determining the effect size associated with the intervention under
examination (Au, Castro, & Krishnan, 2007). In RCTs of health care interventions, stan-
dard care (also known as treatment-as-usual, usual care or routine care) is frequently
employed as the control condition to establish if the intervention is a signiﬁcant
improvement over existing practice (Freedland, Mohr, Davidson, & Schwartz, 2011).
This research design allows a direct comparison between current and an alternative
practice, and thus allows policy-makers to judge the appropriateness of innovations in
health care (e.g. through economic evaluations, see Evers, Hiligsmann, & Adarkwah,
2015).
However, the use of standard care control groups has been the subject of much debate;
with many pointing out that what constitutes standard care is rarely clear (Burns, 2009;
Dawson et al., 2009; Freedland et al., 2011; Mohr et al., 2009; Thompson & Schoenfeld,
2007). Freedland et al. (2011) noted that two trials may include a standard care condition,
but this implies few similarities beyond their names. Indeed, standard care has been shown
to vary even for the same disease or condition (Burns et al., 2007; de Bruin, Viechtbauer,
Hospers, Schaalma, & Kok, 2009). This is perhaps unsurprising as health care provision
and spending can differ between countries (Anderson, Reinhardt, Hussey, & Petrosyan,
2003), updated guidelines and technologies are introduced at variable rates (Cappellaro,
Fattore, & Torbica, 2009) and what is considered to be best practice evolves with new
research ﬁndings. Therefore, the composition of standard care may considerably differ
across hospitals, countries and over time.
This variation in health care practices raises important issues for the interpretation
and generalisability of RCTs of health behaviour change interventions; particularly
where standard care is used as the control condition. For example, an intervention com-
pared with highly effective standard care practices could yield a lower effect size than
the same intervention compared against less-effective care. Unfortunately, as standard
care conditions are often inadequately described (Burns, 2009; Mohr et al., 2009), it is
difﬁcult to conclude whether or not a positive trial is the result of an effective interven-
tion or low-efﬁcacy standard care.
Recent research examining interventions to enhance HIV antiretroviral therapy
adherence has demonstrated the substantial inﬂuence that variation in standard care
quality can have on control group outcomes (de Bruin et al., 2009). This, in turn, can
distort effect sizes and lead to inaccurate conclusions when synthesising the ﬁndings
from multiple RCTs (de Bruin et al., 2010). As a result, there are calls for standard care
quality to be assessed and reported in future RCTs allowing for control of this in
meta-analyses (de Bruin et al., 2009, 2010).
A similar problem in terms of variation in standard care quality potentially affects
trials involving young people with type 1 diabetes. Given the complex nature of diabe-
tes self-management and the necessity for a high level of patient involvement in daily
care, the composition of standard care is likely to involve a range of behaviour change
techniques that may impact on both medical and psychological outcomes. In this paper,
we examine recent behaviour change interventions for young people with type 1 diabe-
tes to determine i) the information provided about standard care control conditions in
published articles; ii) standard care quality across trials via author completed checklists;
and iii) the inﬂuence of standard care quality on medical and psychological outcomes
in control groups in these interventions.
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Method
Literature search and selection procedure
Systematic searches of electronic databases (MEDLINE, Web of Knowledge,
PsycINFO, CINHAL, Embase, ProQuest, and Cochrane database of systematic reviews
and Conference proceedings citation index) were conducted to identify RCTs of behav-
iour change interventions, published between July 1999 and November 2012, for young
people with type 1 diabetes. Search terms were variants on: type 1 diabetes, psychologi-
cal interventions and RCTs (see supplementary materials). We included trials that
involved young people aged 8–21 years, diagnosed with type 1 diabetes for at least
6 months and measured glycated haemoglobin (HbA1c or GhB) or a validated
psychological measure. Non-English language articles and samples with an additional
co-morbid chronic illness were excluded. Reference lists and future citations were also
examined for additional articles (i.e. the ancestry approach – Johnson & Eagly, 2000).
The search strategy yielded a total of 32,102 articles from which non-eligible studies
were removed using database ﬁlters. This left 552 abstracts to be screened with 48 arti-
cles extracted for further review. Overall, there was substantial agreement between
reviewers (k = .85, p < .001) with 20 RCTs incorporating a standard care control
described across 26 published articles included in the review. The ﬂow of information
through the review process can be seen in Figure 1.
Published descriptions of standard care
Published manuscripts were examined individually and any details pertaining to
standard care practices in each trial were extracted by two researchers (KA, CE). When
multiple articles describing one RCT were present (e.g. follow-up reports), details were
collated to establish as much detail as possible about standard care. This means that in
the trial led by Wysocki, three articles were consulted (Wysocki, Greco, Harris, Bubb,
& White, 2001; Wysocki et al., 1999, 2000); in the trial led by Ellis four articles were
consulted (Ellis et al., 2005a, 2005b; Ellis, Templin, et al., 2007; Ellis, Yopp, et al.,
2007) and in the trial led by de Wit, two articles were consulted (de Wit et al., 2008,
2010).
Assessment of standard care quality
To assess standard care quality, we adapted a checklist developed for use in highly
active antiretroviral therapy adherence trials (de Bruin et al., 2009). For example, ‘feed-
back of CD4 and viral load’ was amended to ‘feedback on most recent HbA1c/A1c’.
Other inappropriate items were removed. We derived additional activities from descrip-
tions provided in selected articles and discussions with local Diabetes Specialist Nurses.
The ﬁnal checklist consisted of 19 activities (see Table 1) which were then classiﬁed as
behaviour change techniques using the taxonomy described by Michie et al. (2011).
Activities were coded independently by two researchers (KA, CE) with 100% agree-
ment. Potential checklist responses were ‘Never’, ‘For some patients’, ‘For most
patients’, ‘For all patients’ and ‘Don’t know’.
We derived a summed score for standard care quality for each trial by scoring
‘Never’ and ‘Don’t know’ responses as 0, ‘For some patients’ as 1, ‘For most patients’
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as 2 and ‘For all patients’ as 3. This yielded a theoretical range of 0–57, with higher
scores indicating better standard care quality. Additional questions were included to
determine the frequency of scheduled appointments, the type of clinic where care was
administered (e.g. paediatric, adolescent and adult) and the health professionals involved
in care. We contacted primary authors of trials to complete this checklist retrospectively
to establish which items were routinely delivered as part of standard care.
Statistical analyses
Effect sizes (d) for glycaemic control (HbA1c or GhB) and psychological outcomes
using pre- and post-mean scores, pre- and post-standard deviations and pre/post
correlations in the control group were calculated using comprehensive meta-analysis
version 2 (Borenstein, Hedges, Higgins, & Rothstein, 2005). As pre/post control group
Figure 1. Flow of information through review process.
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correlations are rarely reported, we calculated effect sizes and assumed positive correla-
tions of .25, .5 and .75 if the actual value was unknown as described by Norris, Lau,
Smith, Schmid, and Engelgau (2002). As these approaches yielded essentially identical
results, the ﬁndings reported in this paper are based on a correlation of .5. To assess the
internal reliability of the standard care quality checklist we computed Cronbach’s alpha.
Random effects meta-analyses were run using the metan command on Stata 12.1
(StataCorp, 2012; default settings), with heterogeneity assessed via Cochran’s Q test
and the I2 Statistic (Higgins, Thompson, Deeks, & Altman, 2003). Where heterogeneity
was signiﬁcant, subgroup analyses of high vs. low standard care quality (calculated via
a median split) were conducted to give an indication of relative efﬁcacy. Standard care
quality was then entered as a main predictor in a mixed-effects meta-regression model
(metareg and default settings) both individually and in models containing potential con-
founding trial features (mean age of participants at baseline, gender, attrition, glycaemic
control measure and whether only those with poor glycaemic control were selected),
using control group effect sizes as the outcome measure.
Table 1. Standard care activities assessed and relevant behaviour change techniques.
Standard care activity
Behaviour change technique (Michie et al.,
2011)
General information (verbal or written) about
diabetes management
Provide information on how to perform the
behaviour
Information about the consequences of sub-optimal
control
Provide information on consequences of the
behaviour to the individual
Provide contact details for relevant support groups Plan social support/social change
Feedback on most recent HbA1c /A1c Provide feedback on performance
Encouragement of regular monitoring of blood
glucose levels
Prompt self-monitoring of behaviour
outcome
Discuss common barriers and ways to overcome
them
Prompt barrier identiﬁcation/ problem-
solving
Involve family members in diabetes self-care Plan social support/social change
Set personal goals for diabetes management
(behaviour)
Goal setting (behaviour)
Set personal targets for optimal HbA1c or
Equivalent (outcome)
Goal setting (outcome)
Identify individual problems relating to diabetes
management and generate solutions
Prompt barrier identiﬁcation/ problem-
solving
Use of alarms, cues or reminders to complete
diabetes tasks
Teach to use prompts/cues
Help plan for holidays, special events and sick
days
Relapse Prevention/ Coping Planning
Liaison with relevant others (e.g. schools and
employers) about diabetes
Plan social support/social change
Provide annual review Provide feedback on performance
Adherence to a dietary plan (e.g. carb counting) Action Planning
More frequent contact for those with poor control
or most difﬁculties
Additional: Service Provision
Contact with a Dietitian Additional: Service Provision
Contact with a psychologist Additional: Service Provision
Access to 24 h telephone or online support for
acute problems
Additional: Service Provision
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Results
(1) Information provided about standard care control conditions in published articles
Standard care details provided in published articles for each trial are shown in
Table 2. Of the 20 trials, 16 (80%) reported frequency with which patients were seen as
part of standard care, which ranged from monthly to every six months. Some details
regarding the environment where care was administered were reported in 18 RCTs
(90%) with different locations reported across trials. Nine trials (41%) included informa-
tion about health professionals involved in standard care. There was considerable vari-
ety in the make-up of teams involved in standard care, ranging from only paediatricians
to large multidisciplinary teams. Additional features of standard care were explicitly
reported in a small number of trials. Based on this assessment of published information,
we concluded that the information provided about standard care was limited to service-
level information, and it was not possible to determine the activities and behaviour
change techniques delivered to control group participants.
(2) Standard care quality across trials via author completed checklists
Seventeen authors completed and returned the standard care checklist (85% response
rate). Of these, 16 reported scheduling contact with patients every 3 months, with one
reporting scheduling contact every 6–8 months. The type of clinic where care was admin-
istered was variously described as paediatric (n = 11), paediatric and adolescent (n = 5)
and adolescent only (n = 1). The number of professionals involved in standard care ranged
from 3 to 7 (M = 4.71 ± 1.15). In terms of checklist responses, total standard care activi-
ties delivered to all participants ranged from 2 to 15 (M = 9.94 ± 3.96). The majority of
authors were aware of standard care practices with relatively few ‘Don’t Know’ responses
(never: n = 12; up to 20%: n = 3; between 20 and 40%: n = 2)1. Computed scores for
standard care quality ranged from 27 to 52 (M = 40.82 ± 7.50; see Figure 2) and the
checklist as a whole was found to be internally consistent (α = .78).
(3) The inﬂuence of standard care quality on medical and psychological control
group outcomes
In terms of glycaemic control, 14 trials included sufﬁcient details for inclusion in a
meta-analysis. This yielded a total sample of 508 control group participants. Pooling
these in a random effects analysis (see Figure 3) produced a non-signiﬁcant overall con-
trol group effect size of .07 (95% CI: −.8 to .22). Cochran’s Q test revealed signiﬁcant
heterogeneity across trials (Q(13) = 31.85, p = .003) with the I2 Statistic showing mod-
erate variation (59.2%) in effect sizes attributable to heterogeneity.
Based on a median split, trials with higher standard care quality scores (>42) had a lar-
ger pooled effect size (d = .13, 95% CI: −.09 to .35) than those with lower standard care
quality (d = .02, 95% CI: −.19 to .21) (see Figure 4). However, meta-regression analysis
revealed standard care quality was not a signiﬁcant predictor of effect size when consid-
ered individually (t = −.31, p > .05) or when considered in models including potentially
confounding trial features (mean age of participants at baseline, gender, attrition, glycae-
mic control measure and whether only those with poor glycaemic control were selected),
none of which signiﬁcantly explained the variation between trials (all p’s > .05).
For psychological outcomes, eight trials included sufﬁcient details for inclusion.
This yielded a sample of 340 control group participants. A random effects meta-analysis
90 K. Ayling et al.
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(see Figure 5) revealed an overall effect size of .05 (95% CI: −.08 to .17). Psychologi-
cal outcomes in the control groups were found to be relatively homogenous (Q(7) =
8.72, p > .05; I2 = 19.7%). However, as sources of heterogeneity should be explored
even when the overall test for heterogeneity is not signiﬁcant (Thompson & Higgins,
2002), further moderator analyses were conducted.
Figure 2. Variability in standard care quality.
Figure 3. Forest plot of standardised effects on glycaemic control.
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As was the case for glycaemic control, trials with higher standard care quality
scores (>42) had a larger pooled effect size on psychological outcomes (d = .12, 95%
CI: −.03 to .26) than those with lower standard care quality (d = −.04, 95% CI: −.29 to
.21) (see Figure 6). Meta-regression analysis revealed a trend towards standard care
quality as a predictor of effect size (t = 1.61, p = .158) when considered individually
but this was not apparent when considered in models that included potentially
confounding trial features.
Figure 4. Bubble plot of standardised effects on glycaemic control against standard care quality.
Figure 5. Forest plot of standardised effects on psychological outcomes.
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Discussion
Previous research has illustrated the importance of care quality delivered to control
groups in determining effect sizes in RCTs of HIV antiretroviral adherence interventions
(de Bruin et al., 2009, 2010). In this study, we aimed to describe standard care report-
ing and provision in RCTs of behaviour change interventions for young people with
type 1 diabetes and the implications for interpreting trial outcomes.
Our results demonstrate that the reporting of standard care in published RCTs of
behaviour change interventions for young people with type 1 diabetes is limited, with
many articles providing little or no details about what constitutes standard care. Details
most frequently reported in published articles were service-level features (e.g. clinic
type) rather than information about speciﬁc activities designed to change behaviour or
improve outcomes. This suggests that little weight is given to describing standard care,
in part, perhaps a response to word restrictions in publications, but also perhaps under
the assumption that standard care does not differ across health centres. However, even
given the limited descriptions in trials we assessed, there was considerable variation in
standard care. There were differences in scheduled time intervals of routine appoint-
ments, staff involved and activities that were reported as part of standard care.
This variation in standard care was conﬁrmed by authors’ responses to a retrospec-
tive checklist of standard care activities. In line with the argument that poor reporting is
partly a response to word restrictions in published articles, authors described a greater
number of standard care activities than reported in published articles, with previously
unreported behaviour change techniques often forming part of care. Standard care qual-
ity differed substantially between trials, a ﬁnding congruent with previous research (de
Bruin et al., 2009), suggesting that variation in standard care may well be the norm in
clinical care for chronic conditions.
We also examined the effect of this variation on control group outcomes. Control
groups receiving better standard care quality showed larger positive effect sizes than
those with lower standard care quality for both glycaemic control and psychological
Figure 6. Bubble plot of standardised effects on psychological outcomes against standard care
quality.
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outcomes. This would impact on effect sizes calculated for interventions; with those
interventions compared against higher standard care quality appearing less effective than
if they were compared against a lower quality standard care. However, when entered as
a predictor in meta-regression analyses, standard care quality did not reach statistical
signiﬁcance. In part, this may be due to lack of power, given the relatively small num-
ber of interventions we identiﬁed for young people with type 1 diabetes. Furthermore,
assuming most participants were receiving standard care prior to baseline measures, it is
likely the changes captured by our effect sizes across the course of the trial only
represent part of the overall inﬂuence of standard care.
Despite the inconclusive nature of our ﬁndings in terms of impact on control group
outcomes, the evidence we present of substantial variation in standard care quality and
limited reporting in RCTs is of considerable concern. Previous work has demonstrated
the impact of standard care variation on effect sizes and the outcomes of meta-analyses
(de Bruin et al., 2009, 2010) an issue which is compounded when reporting of standard
care is poor. Despite recommendations that control conditions are described as fully as
intervention conditions (Zwarenstein et al., 2008) it seems that in many cases the
reporting of control conditions is demonstrably not a priority.
Strengths and limitations
We successfully adapted a checklist previously used to assess standard care quality in
HIV antiretroviral adherence trials (de Bruin et al., 2009) and applied it to trials of
behaviour change interventions for young people with type 1 diabetes. While the most
signiﬁcant amendment to the checklist involved rewording of items to be relevant for
diabetes care, it is important to highlight a difference in terms of response options. In
the original checklist, authors were asked to respond ‘yes’, ‘no’ or ‘don’t know’. In our
version of the checklist, authors were asked to indicate which activities were routinely
delivered using more differentiated response categories (‘never’; ‘for some patients’;
‘for most patients’; ‘for all patients’; and ‘don’t know’). Use of these more differenti-
ated response categories has the potential advantage to capture when an activity is
delivered to only some patients. However, given that many authors were necessarily
recalling how standard care was delivered many years previously, we cannot be certain
about the accuracy with which they were able to report such differences.
A further limitation of this method is that it relies on retrospective accounts of care,
at the time of the trial, in some cases over a decade earlier. In addition, trial authors
may not themselves have been personally involved in delivering standard care. Due to
the limited nature of standard care reporting in trials it was not feasible to derive a stan-
dard care quality score from published articles. With improved reporting of standard
care, future researchers will be able to assess standard care quality from published
articles without needing to contact authors many years post-trial.
This study beneﬁts from systematic searches, pre-determined inclusion criteria that
help minimise selection bias and a high response rate from trial authors. We found our
checklist for standard care quality to be internally reliable, suggesting the checklist itself
captures an underlying factor, which could reasonably be described as the quality of
diabetes standard care or adherence counselling. While many of the items were adapted
from the checklist developed by de Bruin et al. (2009), additional checklist items were
derived in conjunction with informal discussions with consultants and diabetes nurses
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working in our centre. Further development of the checklist should include consultation
with those working in other centres to ensure a comprehensive list of activities that
may form part of standard care.
The checklist described in this paper was designed to assess if, and to what propor-
tion of participants, activities are delivered as part of standard care. However, it does
not give insight into how well some of these activities are employed (e.g. the quality/
extent of activities). Such an examination goes beyond the scope of this paper. How-
ever, we would argue that in future reporting, it is essential to include an improved
description of standard care and some rationale for why each activity or technique is
considered appropriate. Finally, authors should include, where possible, some examples
of what each activity involved (e.g. types of goals set and plans made). Only in this
way will we be able to assess which behaviour change techniques are being delivered
as part of standard care and their role in the outcomes of RCTs.
Concluding remarks
RCTs are generally considered to represent the ‘gold standard’ when testing the efﬁcacy
of health behaviour change interventions (Coates, 2010). This special issue of Psychol-
ogy & Health explores the numerous biases that can potentially undermine or distort
outcomes using this methodology and suggests ways to both acknowledge and/or miti-
gate them (e.g. de Bruin, McCambridge, & Prins, 2015). In this paper, we have
explored how poor reporting of standard care limits generalisabilty and potentially intro-
duces bias. There is now ample evidence that standard care for chronic conditions is
not uniform across trials. In the case of multi-centre trials, it is important that research-
ers establish that all participating centres conform to a basic standard care quality at the
start of the trial and that any remaining differences between participating centres are
adequately described.
We echo the call of de Bruin et al. (2009) that those conducting future RCTs give
greater priority to describing what constitutes ‘standard care’ in their trial. At least for
trials involving type 1 diabetes, the checklist developed in this study may be a useful
tool in this regard. If authors decide against using this checklist in favour of prose-
based descriptions, we recommend they at least use language similar to that used in the
checklist as this allows for coding of behaviour change techniques. Written descriptions
of standard care should extend beyond service-level details and focus on active compo-
nents of care (e.g. behaviour change techniques). We acknowledge that space is often
limited in published articles, yet detailed descriptions could be referenced and made
available online. This call shares similarities with the recent focus on the need for
improved reporting of intervention conditions in behaviour change interventions (Craig
et al., 2008; Michie & Prestwich, 2010). We argue, as have others (Bishop,
Fenge-Davies, Kirby, & Geraghty, 2015; Williams, 2010), that it is equally important to
consider and describe the nature of the control group since this plays an integral role in
evaluation of an RCT.
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Note
1. The results presented in the following sections remain unchanged when those who did not
know about standard care practice (n = 2,>20%) are removed from the analyses.
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